Abstract
Free-Cog is a recently described, hybrid screening instrument incorporating tests of cognitive and executive function. In this study, Free-Cog was reformulated as separate tests of cognitive function and executive function to examine whether this might improve screening accuracy for cognitive impairment (dementia and mild cognitive impairment) compared to the standard, unitary Free-Cog. The two separate tests, designated “Free-Cog-Cog” and “Free-Cog-Exec,” were either combined using the Boolean logical “AND” and “OR” operators (serial and parallel combination) or used to construct a stepwise decision tree. Serial combination improved specificity and positive predictive value whereas parallel combination improved sensitivity, findings typically observed when applying these operators. Stepwise application identified groups with high and low probability of cognitive impairment but failed to adequately differentiate those in the intermediate uncertain diagnosis group. Although the dataset used was relatively small, the findings of this study suggest little benefit for reformulations of Free-Cog compared to the standard, unitary instrument.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Walton Centre for Neurology and Neurosurgery gave ethical approval for this work (N310)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
